Drug Research
Caprion-HistoGeneX, Viroclinics-DDL Announce COVID-19 Research Partnership
Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target infectious...
News
Pfizer and BioNTech Announce Early Positive Data from an...
Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program, Project Lightspeed, against SARS-CoV-2, were published online in...
News
Gilead Submits New Drug Application to U.S. FDA for...
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. FDA for Veklury® (remdesivir), an investigational antiviral for the...
News
Novavax Inc and Serum Institute of India Announce Development...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced a license agreement with Serum Institute of India Private Limited (SIIPL)...
News
Innovent and Eli Lilly Announce Acceptance of a Supplemental...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major...
News
Evotec receives CARB-X funding for Resolutes antibiotic project
Evotec SE announced that the Company has entered into a new partnership with the Biotech company Resolute Therapeutics to combat infectious diseases and antimicrobial resistance....
News
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive...
WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr. Jian...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.